Prabhakar N R, Runold M, Yamamoto Y, Lagercrantz H, Cherniack N S, von Euler C
Nobel Institute for Neurophysiology, Karolinska Institute, Stockholm, Sweden.
Acta Physiol Scand. 1987 Sep;131(1):63-71. doi: 10.1111/j.1748-1716.1987.tb08206.x.
Since substance P (SP)-like immunoreactivity has been demonstrated in vagal sensory fibres of bronchopulmonary origin, it was considered of interest to (1) characterize the pattern of responses to SP injected into the pulmonary as well as the systemic arterial system, and (2) assess the types of vagal afferents that are affected by SP. Experiments were performed on 15 pentobarbital-anaesthetized, spontaneously breathing rabbits. Efferent phrenic nerve activity was monitored as an index of central respiratory neural output. Intra-atrial injections of SP into the pulmonary circulation (100 ng kg-1) increased the respiratory rate, and peak integrated phrenic amplitude by 47 +/- 8 and 40 +/- 4%, respectively, above the controls. In addition, SP elicited augmented breaths (ABs) within 2-3 s in 67% of the trials. In contrast to right atrial injections, no ABs and no significant changes in respiratory rate were observed in response to intra-aortic injections of SP (100 ng kg-1). Tidal phrenic activity rise after aortic injections of SP was significantly less as compared with right atrial administrations of SP. Since both routes of administration decreased the arterial blood pressure to the same extent, these respiratory responses were not likely secondary to cardiovascular changes. After administration of an SP antagonist (D-Arg-D-Trp7,9, Leu11, SP), respiratory responses to SP were significantly attenuated. Also, the rate of occurrence of ABs elicited by releasing the tracheal occlusions was reduced (control 95 vs. 14% SP antagonist). Bilateral vagotomy abolished the tachypnoeic response and reduced the magnitude of the phrenic nerve increments caused by right atrial injection of SP.(ABSTRACT TRUNCATED AT 250 WORDS)
由于在支气管肺起源的迷走感觉纤维中已证实存在P物质(SP)样免疫反应性,因此有必要(1)描述注入肺循环以及体循环动脉系统的SP的反应模式,以及(2)评估受SP影响的迷走传入神经的类型。实验在15只戊巴比妥麻醉、自主呼吸的兔子身上进行。监测膈神经传出活动作为中枢呼吸神经输出的指标。向肺循环中经心房注射SP(100 ng/kg)可使呼吸频率增加,膈神经综合峰值幅度分别比对照组增加47±8%和40±4%。此外,在67%的试验中,SP在2 - 3秒内引发增强呼吸(ABs)。与右心房注射不同,经主动脉注射SP(100 ng/kg)未观察到ABs,呼吸频率也无显著变化。主动脉注射SP后膈神经潮气量活动的升高明显低于右心房注射SP。由于两种给药途径使动脉血压降低的程度相同,这些呼吸反应不太可能继发于心血管变化。给予SP拮抗剂(D - Arg - D - Trp7,9, Leu11, SP)后,对SP的呼吸反应明显减弱。此外,解除气管阻塞引发的ABs发生率降低(对照组为95%,SP拮抗剂组为14%)。双侧迷走神经切断术消除了呼吸急促反应,并降低了右心房注射SP引起的膈神经增量幅度。(摘要截断于250字)